Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Breath Actuated Inhalers Market by Type (Single Dose, Multi-dose), By Application (Asthma, COPD, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Breath Actuated Inhalers Market by Type (Single Dose, Multi-dose), By Application (Asthma, COPD, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133773 3300 Medical Devices & Consumables 377 243 Pages 4.8 (44)

Market Overview:

The global breath actuated inhalers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, such as asthma and COPD, and the growing demand for technologically advanced inhalers. The global breath actuated inhalers market is segmented on the basis of type, application, and region. On the basis of type, it is divided into single dose and multi-dose inhalers. Single dose inhalers are further classified into pressurized metered dose inhaler (pMDI) and dry powder inhaler (DPI). Multi-dose inhaled are further classified into nebulizers and autoinhalers. On the basis of application, it is divided into asthma, COPD other respiratory diseases), which include bronchitis chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), pneumonia,, idiopathic pulmonary fibrosis IPF,, sarcoidosis,, lung cancer,, tuberculosis). Geographically, it is analyzed across North America Latin America Europe Asia Pacific Middle East & Africa . Breath actuated Inhaler Devices have been used therapeutically for over 50 years; however their use has increased significantly in recent times due to technological advancements that have made these devices more user friendly with better outcomes.

Global Breath Actuated Inhalers Industry Outlook

Product Definition:

Breath Actuated Inhalers are devices that deliver medication to the lungs through a metered dose inhaler. This type of inhaler is activated when the user takes a breath in, which causes a spray of medication to be released. This type of inhaler is important because it allows for more accurate doses than other types of inhalers, and it also helps to ensure that all the medication reaches the lungs.

Single Dose:

Single dose inhalers (SDIs) are a class of drug delivery devices used to deliver medication in one administration. They comprise a dose, which is released at a precise time and place by the inhalation device. The most common application of SDIs is for the treatment of asthma where multiple daily doses are not feasible or when quick acting drugs are required.

The global market for SDI's was valued at USD 2,867 million in 2016.


Multi-dose is a device used in breath actuated inhalers. It consists of an ampoule containing dose and a valve which can be attached to the inhaler. The multi-dose inhaler delivers dose by the compressed air from the propellant chamber and it works as an asthma relief medication.

The advantages of using multi-dose are that it reduces medicine dosage, improves patient compliance, increases treatment efficacy & satisfaction and reduces adverse effects related to drug consumption.

Application Insights:

Asthma held the largest share of the application segment in 2017. This is attributed to high usage rates of inhalers for asthma treatment and increasing prevalence of asthma. According to data published by Global Asthma Report, around 300 million people across the world suffer from asthma. Prevalence rate for this disease is highest in North America and Europe followed by Asia Pacific region.

According to a study conducted by CDC between 2010-2012, it was estimated that around 47% adults living with bronchitis or emphysema were taking some form of prescription medicine while 43% were using over-the-counter (OTC) medicines for their coughs and 38% had visited a healthcare professional about their coughs and/or wheezing during the past year in U.S., Canada as well as European countries including United Kingdom, Germany Ireland France Spain Italy Portugal etc.

Regional Analysis:

North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing R&D investments and technological advancements in devices. Moreover, high awareness levels regarding chronic respiratory diseases and their treatment options are also contributing towards growth in this region.

Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising disposable income, improving healthcare infrastructure, growing target population base with increased demand for inhalers due to rising prevalence of COPD and asthma as well as other chronic respiratory diseases (CORD). Furthermore, economic development coupled with rapid industrialization has led to an increase in production of breath actuated inhalers across emerging countries such as China & India which will further boost regional market growth during the estimated time span.

The European market was valued at USD X million in 2017.

Growth Factors:

  • Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This is leading to an increase in the demand for breath actuated inhalers as they are the most effective way to treat these diseases.
  • Technological advancements: The technology used in breath actuated inhalers is constantly evolving, making them more efficient and easier to use. This is resulting in an increase in their popularity among patients and healthcare professionals alike.
  • Growing awareness about the benefits of breath actuated inhalers: There is a growing awareness about the benefits of using breath actuated inhalers, such as improved patient compliance and better treatment outcomes. This is helping to drive demand for these devices worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Breath Actuated Inhalers Market Research Report

By Type

Single Dose, Multi-dose

By Application

Asthma, COPD, Other

By Companies

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Meda, Novartis, Schering/Merck

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Breath Actuated Inhalers Market Report Segments:

The global Breath Actuated Inhalers market is segmented on the basis of:


Single Dose, Multi-dose

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Asthma, COPD, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GlaxoSmithKline
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Chiesi
  5. Cipla
  6. 3M
  7. Hovione
  8. Mannkind
  9. Meda
  10. Novartis
  11. Schering/Merck

Global Breath Actuated Inhalers Market Overview

Highlights of The Breath Actuated Inhalers Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Single Dose
    2. Multi-dose
  1. By Application:

    1. Asthma
    2. COPD
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Breath Actuated Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Breath Actuated Inhalers Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Breath Actuated Inhalers (BAI) are a type of medical device that helps people with breathing problems to breathe more easily. They work by using air pressure to help the person inhale and exhale.

Some of the major players in the breath actuated inhalers market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Meda, Novartis, Schering/Merck.

The breath actuated inhalers market is expected to register a CAGR of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Breath Actuated Inhalers Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Breath Actuated Inhalers Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Breath Actuated Inhalers Market - Supply Chain
   4.5. Global Breath Actuated Inhalers Market Forecast
      4.5.1. Breath Actuated Inhalers Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Breath Actuated Inhalers Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Breath Actuated Inhalers Market Absolute $ Opportunity

5. Global Breath Actuated Inhalers Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Breath Actuated Inhalers Market Size and Volume Forecast by Type
      5.3.1. Single Dose
      5.3.2. Multi-dose
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Breath Actuated Inhalers Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Breath Actuated Inhalers Market Size and Volume Forecast by Application
      6.3.1. Asthma
      6.3.2. COPD
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Breath Actuated Inhalers Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Breath Actuated Inhalers Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Breath Actuated Inhalers Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Breath Actuated Inhalers Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Breath Actuated Inhalers Demand Share Forecast, 2019-2029

9. North America Breath Actuated Inhalers Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Breath Actuated Inhalers Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Breath Actuated Inhalers Market Size and Volume Forecast by Application
      9.4.1. Asthma
      9.4.2. COPD
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Breath Actuated Inhalers Market Size and Volume Forecast by Type
      9.7.1. Single Dose
      9.7.2. Multi-dose
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Breath Actuated Inhalers Demand Share Forecast, 2019-2029

10. Latin America Breath Actuated Inhalers Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Application
      10.4.1. Asthma
      10.4.2. COPD
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Type
      10.7.1. Single Dose
      10.7.2. Multi-dose
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Breath Actuated Inhalers Demand Share Forecast, 2019-2029

11. Europe Breath Actuated Inhalers Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Application
      11.4.1. Asthma
      11.4.2. COPD
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Type
      11.7.1. Single Dose
      11.7.2. Multi-dose
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Breath Actuated Inhalers Demand Share, 2019-2029

12. Asia Pacific Breath Actuated Inhalers Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Application
      12.4.1. Asthma
      12.4.2. COPD
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Type
      12.7.1. Single Dose
      12.7.2. Multi-dose
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Breath Actuated Inhalers Demand Share, 2019-2029

13. Middle East & Africa Breath Actuated Inhalers Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Application
      13.4.1. Asthma
      13.4.2. COPD
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Type
      13.7.1. Single Dose
      13.7.2. Multi-dose
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Breath Actuated Inhalers Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Breath Actuated Inhalers Market: Market Share Analysis
   14.2. Breath Actuated Inhalers Distributors and Customers
   14.3. Breath Actuated Inhalers Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GlaxoSmithKline Overview Financials Developments Strategic Outlook
      14.4.2. AstraZeneca Overview Financials Developments Strategic Outlook
      14.4.3. Boehringer Ingelheim Overview Financials Developments Strategic Outlook
      14.4.4. Chiesi Overview Financials Developments Strategic Outlook
      14.4.5. Cipla Overview Financials Developments Strategic Outlook
      14.4.6. 3M Overview Financials Developments Strategic Outlook
      14.4.7. Hovione Overview Financials Developments Strategic Outlook
      14.4.8. Mannkind Overview Financials Developments Strategic Outlook
      14.4.9. Meda Overview Financials Developments Strategic Outlook
      14.4.10. Novartis Overview Financials Developments Strategic Outlook
      14.4.11. Schering/Merck Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us